Wyeth/Altana lose US appeals court bid to halt Teva's generic Protonix
This article was originally published in Scrip
Executive Summary
A US appeals court has unanimously affirmed a September 2007 ruling by a lower court, which denied a motion filed by Wyeth and Altana (now Nycomed) for a preliminary injunction concerning the launch of Teva Pharmaceutical Industries' pantoprazole tablets (a generic version of the erosive GORD treatment Protonix).